EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex

Ginevra Passeri, Joshua Northcote-Smith, Kogularamanan Suntharalingam

Molecules · 2023

DOI: 10.3390/molecules28062506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Ginevra Passeri und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, University of Leicester, Leicester LE1 7RH, UK. Hauptthemen laut MEDLINE: Nanoparticles, Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Leicester.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells (CSCs) are linked to tumour relapse and metastasis, the main reason for cancer-related deaths. The application of polymeric nanoparticles as drug delivery systems to target CSCs is relatively unexplored. Here, we report the encapsulation of a CSC-potent copper(II) complex 1 by two compositionally different methoxy poly(ethylene glycol)-b-poly(D,L-lactic-co-glycolic) acid (PEG–PLGA) copolymers. Specifically, we used PEG–PLGA (5000:10,000 Da, 1:1 LA:GA) and PEG–PLGA (5000:10,000 Da, 4:1 LA:GA) polymers to prepare spherical nanoparticle formulations 1:1 NP15 and 4:1 NP15, respectively, both with a 15% feed of 1. The two formulations show distinct biophysical and in vitro properties. For example, (i) 4:1 NP15 displays a slower payload release profile than 1:1 NP15 in physiologically relevant solutions, (ii) 4:1 NP15 exhibits statistically greater potency towards breast CSCs than bulk breast cancer cells grown in monolayers, whereas 1:1 NP15 is equally potent towards breast CSCs and bulk breast cancer cells, and (iii) 4:1 NP15 shows significantly greater potency towards three-dimensionally cultured mammospheres than 1:1 NP15. This study shows that the release profile and anti-breast CSC properties of PEG–PLGA nanoparticle formulations (containing 1) can be perturbed (and possibly controlled) by modifying the proportion of glycolic acid within the PLGA component.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesBreast NeoplasmsHumansFemalePolylactic Acid-Polyglycolic Acid CopolymerCopperPolyglycolic AcidNeoplasm Recurrence, LocalPolyethylene GlycolsLactic AcidStem CellsDrug CarriersParticle SizePolyesters

Stichwörter der Autor:innen

cancer stem cellscopperpoly lactic-co-glycolic acidpolyethylene glycolpolymeric nanoparticles

Substanzen

Polylactic Acid-Polyglycolic Acid CopolymerCopperPolyglycolic AcidPolyethylene GlycolsLactic AcidDrug Carrierspolyethylene glycol-poly(lactide-co-glycolide)Polyesters

Autor:innen und Institutionen

  • School of Chemistry, University of Leicester, Leicester LE1 7RH, UK.

Förderung

  • University of Leicester

Zitieren

APA

Passeri, G., Northcote-Smith, J., & Suntharalingam, K. (2023). Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex. Molecules. https://doi.org/10.3390/molecules28062506

Vancouver

Passeri G, Northcote-Smith J, Suntharalingam K. Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex. Molecules. 2023. doi:10.3390/molecules28062506

BibTeX
@article{Passeri2023,
  author = {Passeri, Ginevra and Northcote-Smith, Joshua and Suntharalingam, Kogularamanan},
  title = {Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28062506}
}
Kostenlos starten →